Antibody Portfolio:
Spring's antibody portfolio was engineered specifically to meet the needs of the research community. Through our role as a leading antibody development center for Roche, Spring Bioscience is well-positioned to deliver a focused product portfolio to the research market representing the highest value targets for the future diagnosis and prognosis of cancer.